Literature DB >> 28135661

Genetic versus antigenic differences among highly pathogenic H5N1 avian influenza A viruses: Consequences for vaccine strain selection.

Ben Peeters1, Sylvia Reemers2, Jos Dortmans3, Erik de Vries3, Mart de Jong4, Saskia van de Zande2, Peter J M Rottier3, Cornelis A M de Haan5.   

Abstract

Highly pathogenic H5N1 avian influenza A viruses display a remarkable genetic and antigenic diversity. We examined to what extent genetic distances between several H5N1 viruses from different clades correlate with antigenic differences and vaccine performance. H5-specific antisera were generated, and cross-reactivity and antigenic distances between 12 different viruses were determined. In general, antigenic distances increased proportional to genetic distances although notable exceptions were observed. Antigenic distances correlated better with genetic variation in 27 selected, antigenically-relevant H5 residues, than in the complete HA1 domain. Variation in these selected residues could accurately predict the antigenic distances for a novel H5N8 virus. Protection provided by vaccines against heterologous H5N1 challenge viruses indicated that cross-protection also correlates better with genetic variation in the selected antigenically-relevant residues than in complete HA1. When time is limited, variation at these selected residues may be used to accurately predict antigenic distance and vaccine performance.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antigenic distance; Genetic variation; H5N1; Hemagglutinin; Influenza A virus; Vaccine performance

Mesh:

Substances:

Year:  2017        PMID: 28135661     DOI: 10.1016/j.virol.2017.01.012

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  12 in total

1.  Immunity-induced criticality of the genotype network of influenza A (H3N2) hemagglutinin.

Authors:  Blake J M Williams; C Brandon Ogbunugafor; Benjamin M Althouse; Laurent Hébert-Dufresne
Journal:  PNAS Nexus       Date:  2022-08-05

2.  Substrate Binding by the Second Sialic Acid-Binding Site of Influenza A Virus N1 Neuraminidase Contributes to Enzymatic Activity.

Authors:  Wenjuan Du; Meiling Dai; Zeshi Li; Geert-Jan Boons; Ben Peeters; Frank J M van Kuppeveld; Erik de Vries; Cornelis A M de Haan
Journal:  J Virol       Date:  2018-09-26       Impact factor: 5.103

3.  High accumulation in tobacco seeds of hemagglutinin antigen from avian (H5N1) influenza.

Authors:  Yanaysi Ceballo; Kenia Tiel; Alina López; Gleysin Cabrera; Marlene Pérez; Osmany Ramos; Yamilka Rosabal; Carlos Montero; Rima Menassa; Ann Depicker; Abel Hernández
Journal:  Transgenic Res       Date:  2017-10-06       Impact factor: 2.788

4.  Heterologous Humoral Response against H5N1, H7N3, and H9N2 Avian Influenza Viruses after Seasonal Vaccination in a European Elderly Population.

Authors:  Ivan Sanz; Silvia Rojo; Sonia Tamames; José María Eiros; Raúl Ortiz de Lejarazu
Journal:  Vaccines (Basel)       Date:  2017-07-17

5.  Passive inhalation of dry powder influenza vaccine formulations completely protects chickens against H5N1 lethal viral challenge.

Authors:  Jasmine Tomar; Carin Biel; Cornelis A M de Haan; Peter J M Rottier; Nikolai Petrovsky; Henderik W Frijlink; Anke Huckriede; Wouter L J Hinrichs; Ben Peeters
Journal:  Eur J Pharm Biopharm       Date:  2018-10-09       Impact factor: 5.571

6.  Reassortments among Avian Influenza A(H5N1) Viruses Circulating in Indonesia, 2015-2016.

Authors:  Desniwaty Karo-Karo; Rogier Bodewes; Hendra Wibawa; Made Artika; Eko Sugeng Pribadi; D Diyantoro; Widya Pratomo; Agus Sugama; Nani Hendrayani; Iin Indasari; Michael Haryadi Wibowo; David Handojo Muljono; Jan Arend Stegeman; Guus Koch
Journal:  Emerg Infect Dis       Date:  2019-03       Impact factor: 6.883

7.  Localization, epidemic transitions, and unpredictability of multistrain epidemics with an underlying genotype network.

Authors:  Blake J M Williams; Guillaume St-Onge; Laurent Hébert-Dufresne
Journal:  PLoS Comput Biol       Date:  2021-02-10       Impact factor: 4.475

8.  Antiviral Activity of Chicken Cathelicidin B1 Against Influenza A Virus.

Authors:  Lianci Peng; Wenjuan Du; Melanie D Balhuizen; Henk P Haagsman; Cornelis A M de Haan; Edwin J A Veldhuizen
Journal:  Front Microbiol       Date:  2020-03-19       Impact factor: 5.640

9.  Detection of H1 Swine Influenza A Virus Antibodies in Human Serum Samples by Age Group1.

Authors:  Elien Vandoorn; Isabel Leroux-Roels; Geert Leroux-Roels; Anna Parys; Amy Vincent; Kristien Van Reeth
Journal:  Emerg Infect Dis       Date:  2020-09       Impact factor: 6.883

10.  Serological Screening of Influenza A Virus Antibodies in Cats and Dogs Indicates Frequent Infection with Different Subtypes.

Authors:  Shan Zhao; Nancy Schuurman; Malte Tieke; Berit Quist; Steven Zwinkels; Frank J M van Kuppeveld; Cornelis A M de Haan; Herman Egberink
Journal:  J Clin Microbiol       Date:  2020-10-21       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.